Karolinska Development Ab Stock Total Debt
| KDEV Stock | SEK 1.04 0.04 3.70% |
Karolinska Development AB fundamentals help investors to digest information that contributes to Karolinska Development's financial success or failures. It also enables traders to predict the movement of Karolinska Stock. The fundamental analysis module provides a way to measure Karolinska Development's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Karolinska Development stock.
Karolinska |
Karolinska Development AB Company Total Debt Analysis
Karolinska Development's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Karolinska Development AB has a Total Debt of 0.0. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The total debt for all Sweden stocks is 100.0% higher than that of the company.
Karolinska Development AB is currently under evaluation in total debt category among its peers. Total debt of Health Care industry is now estimated at about 1.04 Billion. Karolinska Development adds roughly 0.0 in total debt claiming only tiny portion of equities under Health Care industry.Karolinska Fundamentals
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0168 | |||
| Operating Margin | (14.44) % | |||
| Current Valuation | 247.24 M | |||
| Shares Outstanding | 267.28 M | |||
| Shares Owned By Insiders | 37.17 % | |||
| Shares Owned By Institutions | 5.97 % | |||
| Price To Earning | 7.42 X | |||
| Price To Book | 0.37 X | |||
| Price To Sales | 204.26 X | |||
| Revenue | 2.17 M | |||
| Gross Profit | 2.17 M | |||
| EBITDA | 177.79 M | |||
| Net Income | 170.82 M | |||
| Cash And Equivalents | 42.4 M | |||
| Cash Per Share | 1.85 X | |||
| Debt To Equity | 177.80 % | |||
| Current Ratio | 0.24 X | |||
| Book Value Per Share | 4.56 X | |||
| Cash Flow From Operations | 16.7 M | |||
| Earnings Per Share | 0.86 X | |||
| Target Price | 4.5 | |||
| Beta | 0.4 | |||
| Market Capitalization | 510.26 M | |||
| Total Asset | 1.11 B | |||
| Retained Earnings | (1.85 B) | |||
| Working Capital | 250 M | |||
| Current Asset | 259 M | |||
| Current Liabilities | 9 M | |||
| Z Score | -1.4 | |||
| Net Asset | 1.11 B |
About Karolinska Development Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Karolinska Development AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Karolinska Development using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Karolinska Development AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Karolinska Stock Analysis
When running Karolinska Development's price analysis, check to measure Karolinska Development's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karolinska Development is operating at the current time. Most of Karolinska Development's value examination focuses on studying past and present price action to predict the probability of Karolinska Development's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karolinska Development's price. Additionally, you may evaluate how the addition of Karolinska Development to your portfolios can decrease your overall portfolio volatility.